Sign inJoin waitlistJoin the waitlist

Michael Lidsky

Chief, Section of HPB Surgery · Duke University Hospital

Credentials: · · · · ·

History

Section of HPB Surgery · Duke University Hospital
Present
Duke University Hospital
Present
Duke University Hospital
Present

Memorial Sloan Kettering Cancer Center
2017–2018
Complex General Surgical Oncology
Memorial Sloan Kettering Cancer Center
2016–2018
Surgery
Duke University Hospital
2009–2016
Internal Medicine
Duke University Hospital
2009–2012
Georgetown University School of Medicine
2005–2009

Research

Advances in the treatment of intrahepatic cholangiocarcinoma: An overview of the current and future therapeutic landscape for clinicians
Review · Current Anthropology · 2023 · Last of 6 authors · 478 citations
Going the Extra Mile: Improved Survival for Pancreatic Cancer Patients Traveling to High-volume Centers
Annals of Surgery · 2017 · First of 6 authors · 165 citations
Association of Integrated Care Coordination With Postsurgical Outcomes in High-Risk Older Adults: The Perioperative Optimization of Senior Health (POSH) Initiative
JAMA Surgery · 2018 · 164 citations

Peter Allen
30 papers · 16 as a resident
Sabino Zani
26 papers · 14 as a resident
Daniel Nussbaum
22 papers · 3 as a resident
Kristen Rhodin
17 papers · 17 as a resident
Dan Blazer
14 papers
MD
Michael D'Angelica
14 papers
RT
Ryan Turley
13 papers · 13 as a resident
WJ
William Jarnagin
12 papers
Austin Eckhoff
11 papers · 7 as a resident
Sabran Masoud
11 papers · 11 as a resident
Elishama Kanu
10 papers · 10 as a resident
Hope Uronis
10 papers

Clinical trials

Testing Pump Chemotherapy in Addition to Standard of Care Chemotherapy Versus Standard of Care Chemotherapy Alone for Patients With Unresectable Colorectal Liver Metastases: The PUMP Trial
Principal investigator · Recruiting · Phase 3
ECOG-ACRIN Cancer Research Group
2023–2034
Hepatic Artery Infusion (HAI) Program at Duke University
Principal investigator · Withdrawn
Michael Lidsky, M.D.
2020–2022
Safety of HRX215 in Patients After Minor and Major Liver Resection
Site PI · Recruiting · Phase 1, Phase 2
HepaRegeniX GmbH
2025–2027
Comparing the Clinical Impact of Pancreatic Cyst Surveillance Programs and Associated Biomarkers
Site PI · Recruiting
ECOG-ACRIN Cancer Research Group
2020–2034